Skip to Content
 
Center for International Blood and Marrow Transplant Research

IN23-01

Main Content

Infections within 100 days of idecabtagene vicleucel and impact on survival for relapsed/refractory multiple myeloma: A CIBMTR Analysis

Study #: IN23-01

Study Status: Submitted